(Reuters) -Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to neg[...]
Read more
Health
Teladoc expands Microsoft tie-up to document patient visits with AI
(Reuters) – Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate clinical documentation on the telehealth platform,[...]
Read more
Pfizer, Flagship Pioneering to invest $100 million in drug discovery
(Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medic[...]
Read more
Court blocks curbs on US government contact with social media companies for now
By Brendan Pierson (Reuters) -A U.S. appeals court on Friday temporarily blocked a lower court order that had sharply limited certain Biden administration officials’ and agencies’ contacts[...]
Read more
UnitedHealth’s lower-than-feared costs lift profit, shares
By Bhanvi Satija and Raghav Mahobe (Reuters) -UnitedHealth Group’s quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected jump in medical costs allayed fears that a res[...]
Read more
Eli Lilly to buy Versanis for up to $1.93 billion in obesity drugs push
By Sriparna Roy (Reuters) -Eli Lilly and Co said on Friday it will buy privately held Versanis for potentially up to $1.93 billion to strengthen its position in the fast-growing market for weight-loss[...]
Read more
Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal – WSJ
(Reuters) -Biotech company Roivant Sciences is in talks to sell an experimental drug to treat inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, to Roche in a deal th[...]
Read more
Coca-Cola to see less pain from looming WHO decision on aspartame – analysts
By Savyata Mishra (Reuters) – (This June 30 story has been officially corrected to drop the reference to aspartame being removed from PepsiCo products in 2020, in paragraph 9. A PepsiCo spokespe[...]
Read more
US FDA reviewing concerns over Logan Paul’s PRIME energy drink
(Reuters) – The U.S. Food and Drug Administration said on Wednesday it is reviewing concerns raised by Senate Majority Leader Chuck Schumer against a popular influencer-created energy drink. Sch[...]
Read more